Q4 2021 Holdings
Filed 2022-02-14 | 147 holdings | $743.6M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2022-05-04) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $146.7M | 5,163,517 | 19.7% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $118.9M | 7,128,755 | 16.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $104.3M | 1,180,000 | 14.0% |
| Coherus Biosciences Inc(CHRS) | COM | 19249H103 | $86.3M | 5,407,798 | 11.6% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $71.1M | 2,208,913 | 9.6% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $39.6M | 9,903,879 | 5.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $37.0M | 1,584,052 | 5.0% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $27.4M | 3,188,750 | 3.7% |
| CUE Health Inc(HLTHQ) | COM | 229790100 | $21.2M | 1,580,607 | 2.9% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $16.8M | 11,933,387 | 2.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $11.7M | 48,600 | 1.6% |
| Absci Corporation(ABSI) | COM | 00091E109 | $11.6M | 1,411,776 | 1.6% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $11.4M | 781,236 | 1.5% |
| Adaptive Biotechnologies COR(ADPT) | COM | 00650F109 | $9.9M | 352,804 | 1.3% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $8.9M | 229,807 | 1.2% |
| Cryolife Inc(AORT) | COM | 228903100 | $6.6M | 326,318 | 0.9% |
| Clover Health Investments Co(CLOV) | COM CL A | 18914F103 | $5.6M | 1,500,000 | 0.8% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $3.0M | 80,420 | 0.4% |
| Travere Therapeutics Inc | NOTE 2.500% 9/1 | 761299AB2 | $484.7K | $45,000,000 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $481.7K | 3,283,783 | 0.1% |
| Lianbio | SPONSORED ADS | 53000N108 | $346.9K | 56,319,960 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $306.8K | 26,559,443 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $300.6K | 4,849,912 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $193.3K | 10,127,941 | 0.0% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $187.3K | 1,738,140 | 0.0% |
| Collegium Pharmaceutical Inc | NOTE 2.625% 2/1 | 19459JAA2 | $169.3K | $17,500,000 | 0.0% |
| Meiragtx Hldgs PLC(MGTX) | COM | G59665102 | $165.0K | 6,948,277 | 0.0% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $164.9K | 5,086,727 | 0.0% |
| Prometheus Biosciences Inc | COM | 74349U108 | $125.5K | 3,172,785 | 0.0% |
| VBI Vaccines Inc CDA(VAC2USD) | COM NEW | 91822J103 | $122.5K | 52,335,002 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $108.3K | 6,480,000 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $107.5K | 2,927,565 | 0.0% |
| Nevro Corp | NOTE 2.750% 4/0 | 64157FAC7 | $101.5K | $9,000,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $101.0K | 3,449,915 | 0.0% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $85.9K | 1,863,397 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $75.3K | 2,411,447 | 0.0% |
| Landos Biopharma Inc | COM | 515069102 | $71.4K | 14,869,915 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $68.6K | 1,451,700 | 0.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $61.5K | 7,645,234 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $60.3K | 3,679,845 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $59.7K | 1,943,097 | 0.0% |
| Inhibrx Inc(INBXUSD) | COM | 45720L107 | $58.7K | 1,343,490 | 0.0% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $57.3K | 1,845,555 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $55.0K | 2,360,139 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $51.5K | 1,415,446 | 0.0% |
| Coherus Biosciences Inc | NOTE 1.500% 4/1 | 19249HAB9 | $51.5K | $4,500,000 | 0.0% |
| Nautilus Biotechnology Inc(NAUT) | COM | 63909J108 | $47.2K | 9,111,151 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $46.5K | 500,000 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $44.6K | 3,425,916 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $44.1K | 520,152 | 0.0% |